News

Moderna gets full FDA approval for kids COVID-19 vaccine
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again
The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...
Barchart on MSN7h
What to Expect From Moderna's Next Quarterly Earnings Report
Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...
The Telegraph on MSN4h
Sauvage Agonies vs. Schulemburg Saps football rivalry packed Sportsman's Park in 1930s
The annual football game at Sportsman's Park in the 1930s drew big crowds ...
Science Media Centre2h
expert reaction to media reports that a child has died after contracting measles
Scientists comment on reports that a child has died in a Liverpool hospital after contracting measles. Prof Sir Andrew Pollard FRCPCH FMedSci FRS, Director of the Oxford Vaccine Group, and Ashall ...
Ophthalmology Advisor1h
FDA Fully Approves Moderna’s COVID Vaccine for Some Young Kids
Moderna’s COVID-19 vaccine has received full approval from the US Food and Drug Administration (FDA) for use in children with medical conditions that put them at higher risk of severe illness.